Neurocrine Biosciences
NBIX
#1235
Rank
$14.50 B
Marketcap
$144.14
Share price
-0.35%
Change (1 day)
48.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of March 2024 : $3.47 B

According to Neurocrine Biosciences 's latest financial reports the company's total assets are $3.47 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$3.25 B37.27%
2022-12-31$2.36 B14.29%
2021-12-31$2.07 B19.47%
2020-12-31$1.73 B32.83%
2019-12-31$1.30 B31.5%
2018-12-31$0.99 B21.47%
2017-12-31$0.81 B123.94%
2016-12-31$0.36 B-23.1%
2015-12-31$0.47 B95.36%
2014-12-31$0.24 B57.12%
2013-12-31$0.15 B-21.08%
2012-12-31$0.19 B41.64%
2011-12-31$0.13 B-4.19%
2010-12-31$0.14 B103.94%
2009-12-31$70.81 M-40.08%
2008-12-31$0.11 B-57.28%
2007-12-31$0.27 B-29%
2006-12-31$0.38 B-19.34%
2005-12-31$0.48 B-6.95%
2004-12-31$0.51 B-6.44%
2003-12-31$0.55 B108.21%
2002-12-31$0.26 B-23.04%
2001-12-31$0.34 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$2.84 B-17.95%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.13 B 364.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
$11.4 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.94 B 1,741.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$148.87 B 4,187.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$221.09 B 6,267.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.91 B-73.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.42 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA